United Services Automobile Association Atara Biotherapeutics, Inc. Transaction History

United Services Automobile Association

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 16, 2019	SELL	$19.05 - $41.04 $142,951 - $307,964	-7,504 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$30.9 - $42.97 $25,461 - $35,407	-824 Reduced 9.89%	7,504 $261,000
Q3 2018 Nov 13, 2018	BUY	$35.05 - $43.5 $6,869 - $8,526	196 Added 2.41%	8,328 $344,000
Q2 2018 Aug 10, 2018	BUY	$35.15 - $51.45 $63,164 - $92,455	1,797 Added 28.37%	8,132 $299,000
Q1 2018 May 14, 2018	BUY	$18.0 - $48.35 $114,030 - $306,297	6,335 New	6,335 $247,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $776M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.